Boehringer Ingelheim Fremont, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 83012 (Boehringer Ingelheim Fremont, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
15
Package NDCs
15
Products
15
Active listings
0
Discontinued
7
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 15 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Adalimumab 40 mg/.8mL LIQUID | 83012-0009-10 | — | On market | View → |
| Adalimumab 10 mg/.2mL LIQUID | 83012-0013-10 | — | On market | View → |
| Adalimumab 100 mg/mL LIQUID | 83012-0046-99 | — | On market | View → |
| Adalimumab 50 mg/mL LIQUID | 83012-0045-99 | — | On market | View → |
| Adalimumab 20 mg/.4mL LIQUID | 83012-0012-10 | — | On market | View → |
| Adalimumab 40 mg/.4mL LIQUID | 83012-0011-10 | — | On market | View → |
| Aflibercept 65 mg/mL LIQUID | 83012-0052-99 | — | On market | View → |
| Cyltezo 50 mg/50mg LIQUID | 83012-0036-99 | — | On market | View → |
| Cyltezo 50 mg/50mg LIQUID | 83012-0035-99 | — | On market | View → |
| Cyltezo 50 mg/50mg LIQUID | 83012-0037-99 | — | On market | View → |
| Cyltezo 50 mg/50mg LIQUID | 83012-0038-99 | — | On market | View → |
| Enhertu 22 mg/22mg LIQUID | 83012-0020-99 | — | On market | View → |
| Patritumab 70 g/70g LIQUID | 83012-0021-99 | — | On market | View → |
| Pembrolizumab 25 mg/25mg LIQUID | 83012-0010-99 | — | On market | View → |
| Zenocutuzumab 20 mg/20mg LIQUID | 83012-0023-99 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.